Maspin Modulates Malignant Phenotypes Depending on Subcellular Localization in Pancreatic Ductal Adenocarcinoma Cell Lines
Cancers · 01.06.2026 · 18 (11) · 1815
DOI: 10.3390/cancers18111815 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 01.06.2026. Verfasst von Hirotoshi Mochida und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago 683-8503, Tottori, Japan. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, MEXT/JSPS KAKENHI.
Abstract (Originalsprache)
Background/Objectives: Mammary serine protease inhibitor (maspin) was originally identified as a tumor suppressor gene, as loss of its expression in breast cancer cell lines promotes invasiveness and tumorigenicity. In contrast, normal pancreatic ductal epithelium does not express the maspin protein, and its expression frequency increases as pancreatic intraepithelial neoplasia (PanIN) progresses to pancreatic ductal adenocarcinoma (PDAC). We have previously reported that cytoplasmic-only localization of maspin (cytMaspin) is an independent indicator of poor prognosis in patients with PDAC. However, the functional role of maspin in PDAC remains unclear.
Methods
We investigated the subcellular localization and biological function of maspin in PDAC cell lines using Western blotting, immunofluorescence, RNA-seq, wound-healing assays, and invasion assays.
Results
Endogenous maspin was detected in most PDAC cell lines, and RNA-seq was performed in S2-007 (panMaspin; nuclear and cytoplasmic localization of maspin) and S2-028 (cytMaspin), which were derived from the same parental cell line (SUIT-2). The invasive capability of S2-028 cells (cytMaspin) was higher than that of S2-007 cells (panMaspin), showing upregulation of the ErbB family and axon-guidance pathways. Furthermore, maspin overexpression in PANC-1 and S2-020 cells resulted in panMaspin and cytMaspin, respectively. PANC-1 cells overexpressing maspin showed decreased invasive capability via suppression of HER2 expression and Akt activation.
Conclusions
Although maspin expression has generally been considered an unfavorable prognostic indicator in patients with PDAC, our findings suggest that its biological effects may differ depending on its subcellular localization. Specifically, nuclear localization is linked to less aggressive phenotypes, whereas cytoplasmic localization is associated with more malignant behavior.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago 683-8503, Tottori, Japan.
ORCID-Profile: Hirotoshi Mochida, Tomohiko Sakabe
Förderung
- Japan Society for the Promotion of Science
- MEXT/JSPS KAKENHI
Zitieren
APA
Mochida, H., Sakabe, T., Shingu, T., Makishima, K., & Umekita, Y. (2026). Maspin Modulates Malignant Phenotypes Depending on Subcellular Localization in Pancreatic Ductal Adenocarcinoma Cell Lines. Cancers, 18(11), 1815. https://doi.org/10.3390/cancers18111815
Vancouver
Mochida H, Sakabe T, Shingu T, Makishima K, Umekita Y. Maspin Modulates Malignant Phenotypes Depending on Subcellular Localization in Pancreatic Ductal Adenocarcinoma Cell Lines. Cancers. 2026;18(11):1815. doi:10.3390/cancers18111815
BibTeX
@article{Mochida2026,
author = {Mochida, Hirotoshi and Sakabe, Tomohiko and Shingu, Takayuki and Makishima, Karen and Umekita, Yoshihisa},
title = {Maspin Modulates Malignant Phenotypes Depending on Subcellular Localization in Pancreatic Ductal Adenocarcinoma Cell Lines},
journal = {Cancers},
year = {2026},
volume = {18},
number = {11},
pages = {1815},
doi = {10.3390/cancers18111815}
}
EUVIMED